Answers are grounded in this paper and cite their sources.
Increasing Antimicrobial Resistance (AMR) compromises the treatment of Helicobacter pylori infection globally. This study aimed to use probiotics together with an antibiotic regimen and a proton pump inhibitor to eradicate H. pylori. Stools from positive Helicobacter pylori Stool Antigen (HpSAg), totaling 114 (47.7%) were cultivated on Columbia-based Dent agar (Oxoid) at different times. D Berg’s commercially sourced brand of Lactobacillus rhamnosus/casei probiotic was used. Following biochemical and molecular identification. A per-clinical-factorial-experimental design was employed for the study. Animals, aged 40 weeks old and above were prepared and grouped into six subsets labeled T1 - T6, each defining a particular experimental variable with n = 20. The H. pylori isolates 1 × 108 CFU/ml in normal saline were intraperitoneally administered to the test animals (T2 - T6) over 21 days. Different preparations of probiotics and antibiotics-probiotic therapies were given to the relevant subsets and the outcomes were monitored daily. Fisher’s exact software was used to calculate the error value at 5% (p H. pylori treatment lies in a good Antimicrobial Sensitivity Testing (AST) platform and that only a probiotic-antibiotic regimen can guarantee total eradication (100%) of H. pylori.
No takes yet. Share an insight, caveat, or question.
Ezeumeh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: